OKSANA WILLIAMS: Open Payments
NPI 1316694805 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,625 in 44 payments from 12 companies in 2025. Trend: 2023 $66 · 2024 $764 · 2025 $1,625
Food & beverage: $1,625
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $301 |
| Gilead Sciences, Inc. | 7 | $294 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $216 |
| Janssen Biotech, Inc. | 6 | $196 |
| Phathom Pharmaceuticals, Inc. | 2 | $150 |
| Madrigal Pharmaceuticals | 2 | $144 |
| Regeneron Healthcare Solutions, Inc. | 2 | $143 |
| PFIZER INC. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
Products named: XIFAXAN, TREMFYA, VOQUEZNA, SKYRIZI, REZDIFFRA, DUPIXENT, Livdelzi, RINVOQ.
Industry payments across NM — which companies pay providers there.
